Manufacturer To Pay $10 Million, CEO Indicted in Connection With Marketing of ‘Dummy’ Device

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Manufacturer To Pay $10 Million, CEO Indicted in Connection With Marketing of ‘Dummy’ Device

Stimwave L.L.C. Marketed Implantable Neurostimulation Product Containing a Nonfunctioning Component

Dennis Tosh

March 16, 2023 at 09:44 AM EST

The Department of Justice (DOJ) March 9 announced the unsealing of a three-year non-prosecution agreement with a medical device company related to what the department called “a scheme to create and sell a nonfunctioning dummy medical device for implantation into patients suffering from chronic pain, resulting in millions of dollars in losses to federal health care programs.” ... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Manufacturer To Pay $10 Million, CEO Indicted in Connection With Marketing of ‘Dummy’ Device

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT